首页> 外国专利> NEW SCHEME OF COMBINING CYTOKINE FUSION PROTEIN (IL-2/Fc) AND TRADITIONAL CHINESE MEDICINE COMPOUND 861 FOR ENHANCING IMMUNE RESPONSE OF HEPATITIS B VACCINE AND BREAKING IMMUNE TOLERANCE OF HEPATITIS B VIRUS

NEW SCHEME OF COMBINING CYTOKINE FUSION PROTEIN (IL-2/Fc) AND TRADITIONAL CHINESE MEDICINE COMPOUND 861 FOR ENHANCING IMMUNE RESPONSE OF HEPATITIS B VACCINE AND BREAKING IMMUNE TOLERANCE OF HEPATITIS B VIRUS

机译：细胞因子融合蛋白（IL-2 / Fc）与中药化合物861联合使用可增强乙型肝炎病毒疫苗的免疫反应和打破乙型肝炎病毒的免疫耐受性的新方案

页面导航

摘要
著录项
相似文献

摘要

The invention claims a pharmaceutical composition of a known cytokine fusion protein (IL-2/Fc) and a traditional Chinese medicine compound 861, a pharmaceutical composition and a kit which contains them and a scheme of using them as immunopotentiators for enhancing immune response of hepatitis B vaccine and breaking immune tolerance of hepatitis B virus.

机译：本发明要求保护一种已知的细胞因子融合蛋白（IL-2 / Fc）和中药化合物861的药物组合物，包含它们的药物组合物和试剂盒以及将其用作增强肝炎免疫应答的免疫增强剂的方案B疫苗和破坏乙型肝炎病毒的免疫耐受性。

著录项

公开/公告号WO2008080302A1

专利类型
公开/公告日2008-07-10

原文格式PDF
申请/专利权人 BEIJING YANHUANG QILIN BIOTECHNOLOGY DEVELOPMENT CO. LTD.;ZHENG XINXIAO;WANG BAOEN;TIAN YAN;LI XINMIN;
展开▼

申请/专利号WO2007CN03802
发明设计人 ZHENG XINXIAO;WANG BAOEN;TIAN YAN;LI XINMIN;
展开▼

申请日2007-12-26
分类号A61K38/20;A61K36/486;A61K36/068;A61K36/752;A61K36/53;A61K36/71;A61K36/236;A61K36/481;A61K36/232;A61K36/286;A61K36/233;A61K36/8905;A61K39/29;A61P1/16;A61P31/20;
国家 WO
入库时间 2022-08-21 19:58:23

相似文献

专利
外文文献
中文文献